Evidence map›Paper›PMID 22319036›Full record

ReviewThe Journal of clinical endocrinology and metabolism2012

Homozygous thyroid hormone receptor β-gene mutations in resistance to thyroid hormone: three new cases and review of the literature.

Alfonso Massimiliano Ferrara, Kazumichi Onigata, Oya Ercan, Helen Woodhead, Roy E Weiss, Samuel Refetoff

Open access · bronzeAbstract readCase ReportsComparative StudyReview
In one paragraph

Review in The Journal of clinical endocrinology and metabolism, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 2 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 2 syntheses or guidelines pooled it, 106 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Article
  4. Review
  5. Observational
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Thyroid Hormone Resistance: A 17-Year Follow-up Case Report.Endocrine, metabolic & immune disorders drug targets · 2024
    Article
  14. Review
  15. Article
  16. Article
  17. Expanding the phenotype ofFrontiers in cell and developmental biology · 2023
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Alfonso Massimiliano FerraraDepartment of Medicine, The University of Chicago, MC3090, 5841 South Maryland Avenue, Chicago, Illinois 60637, USA.
Kazumichi Onigata
Oya Ercan
Helen Woodhead
Roy E Weiss
Samuel Refetoff
University of Chicago · USIstanbul University · TRSydney Children's Hospital · AU

Funding

TRANSGENIC COREP60DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI BELL, GRAEME I · 1985 to 2012
$25.5M
THYROID PHYSIOLOGY STUDIES OF INHERITED DISORDERSR37DK015070 · NIDDK · UNIVERSITY OF CHICAGO · PI REFETOFF, SAMUEL · 1989 to 2015
$5.6M
PURCHASING OF A GENETISCAN FOR AUTOMATED KARYOTYPINGS10RR004999 · NCRR · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI PATHAK, S · 1988 to 1988
–
NCRR NIH HHS 5M01RR04999NIDDK NIH HHS P60 DK020595NIDDK NIH HHS P60DK20595NIDDK NIH HHS R37 DK015070NIDDK NIH HHS R37DK15070
6 · The paper itself

Abstract

contextThe most common cause of resistance to thyroid hormone (RTH) is heterozygous thyroid hormone receptor β (THRB) gene mutations. Homozygous mutations in the THRB gene are a rare event.

objectiveIn this study, the clinical findings of three new patients (belonging to two families) homozygous for mutations in the THRB gene are compared to three other families in which affected individuals lack a normal TRβ.

methodsWe conducted clinical studies and genetic analyses.

resultsThe clinical presentation in all three homozygous subjects was unusually severe; their phenotype was characterized by compromised intellectual development, tachycardia, goiter, growth retardation, and hearing loss. This was comparable with one other reported patient homozygous for mutant TRβ, but not in RTH due to THRB gene deletions.

conclusionWe report three new subjects, from two families, in whom RTH was associated with homozygous mutations in the THRB gene. They represent an important addition to the single known patient homozygous for a mutant TRβ. The clinical and laboratory abnormalities indicate a strong dominant-negative effect and are in agreement with data obtained from mice expressing a mutant Thrb in both alleles. This report strengthens the concept that the mutated TRβ interferes with the function of the TRα1 in humans.

Indexed as

MutationAmino Acid SubstitutionChild, PreschoolFemaleGenes, RecessiveHomozygoteHumansInfant, NewbornMalePedigreePoint MutationSeverity of Illness IndexThyroid Hormone Receptors betaThyroid Hormone Resistance SyndromeThyroid Hormone Receptors beta

Identifiers

PMID22319036
PMCPMC3319181
OpenAlexW2164383111

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.